256 related articles for article (PubMed ID: 25582316)
1. Distinct prognostic values of ALDH1 isoenzymes in breast cancer.
Wu S; Xue W; Huang X; Yu X; Luo M; Huang Y; Liu Y; Bi Z; Qiu X; Bai S
Tumour Biol; 2015 Apr; 36(4):2421-6. PubMed ID: 25582316
[TBL] [Abstract][Full Text] [Related]
2. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
3. Mining distinct aldehyde dehydrogenase 1 (ALDH1) isoenzymes in gastric cancer.
Shen JX; Liu J; Li GW; Huang YT; Wu HT
Oncotarget; 2016 May; 7(18):25340-9. PubMed ID: 27015121
[TBL] [Abstract][Full Text] [Related]
4. Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer.
Ma YM; Zhao S
Onco Targets Ther; 2016; 9():1981-8. PubMed ID: 27110126
[TBL] [Abstract][Full Text] [Related]
5. The prognostic roles of ALDH1 isoenzymes in gastric cancer.
Li K; Guo X; Wang Z; Li X; Bu Y; Bai X; Zheng L; Huang Y
Onco Targets Ther; 2016; 9():3405-14. PubMed ID: 27354812
[TBL] [Abstract][Full Text] [Related]
6. ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
Koh YW; Han JH; Haam S; Jung J
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1427-1436. PubMed ID: 30923946
[TBL] [Abstract][Full Text] [Related]
7. Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness.
Shima H; Kida K; Adachi S; Yamada A; Sugae S; Narui K; Miyagi Y; Nishi M; Ryo A; Murata S; Taniguchi H; Ichikawa Y; Ishikawa T; Endo I
Breast Cancer Res Treat; 2018 Aug; 170(3):507-516. PubMed ID: 29693231
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas.
Demir H; Dulgar O; Gulle BT; Turna H; Ilvan S
Bosn J Basic Med Sci; 2018 Nov; 18(4):313-319. PubMed ID: 29924962
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma.
Yang CK; Wang XK; Liao XW; Han CY; Yu TD; Qin W; Zhu GZ; Su H; Yu L; Liu XG; Lu SC; Chen ZW; Liu Z; Huang KT; Liu ZT; Liang Y; Huang JL; Xiao KY; Peng MH; Winkle CA; O'Brien SJ; Peng T
PLoS One; 2017; 12(8):e0182208. PubMed ID: 28792511
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
[TBL] [Abstract][Full Text] [Related]
11. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
Dong Y; Bi LR; Xu N; Yang HM; Zhang HT; Ding Y; Shi AP; Fan ZM
Pathol Res Pract; 2013 Sep; 209(9):555-61. PubMed ID: 23916993
[TBL] [Abstract][Full Text] [Related]
12. High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas.
Madjd Z; Ramezani B; Molanae S; Asadi-Lari M
Asian Pac J Cancer Prev; 2012; 13(6):2973-8. PubMed ID: 22938492
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining.
Gong Y; Wang J; Huo L; Wei W; Ueno NT; Woodward WA
Clin Breast Cancer; 2014 Jun; 14(3):e81-8. PubMed ID: 24461456
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer.
Martín M; Hinojar A; Cerezo L; García J; Lopez M; Prada J; Marín A; Gamallo C
Clin Transl Oncol; 2016 Aug; 18(8):825-30. PubMed ID: 26572760
[TBL] [Abstract][Full Text] [Related]
16. The prognostic roles of circulating ALDH1
Tian S; Xing YN; Xia P
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30305380
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
Ohi Y; Umekita Y; Yoshioka T; Souda M; Rai Y; Sagara Y; Sagara Y; Sagara Y; Tanimoto A
Histopathology; 2011 Oct; 59(4):776-80. PubMed ID: 22014057
[TBL] [Abstract][Full Text] [Related]
18. Expression of ALDH1 and TGFβ2 in benign and malignant breast tumors and their prognostic implications.
Zheng R; Wang J; Wu Q; Wang Z; Ou Y; Ma L; Wang M; Wang J; Yang Y
Int J Clin Exp Pathol; 2014; 7(7):4173-83. PubMed ID: 25120797
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
[TBL] [Abstract][Full Text] [Related]
20. ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer.
Xing P; Dong H; Liu Q; Zhao T; Yao F; Xu Y; Chen B; Zheng X; Wu Y; Jin F; Li J
Cell Physiol Biochem; 2018; 49(3):961-970. PubMed ID: 30184527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]